Marksans Pharma (NSE:MARKSANS) Accounts Payable & Accrued Expense : ₹0 Mil (As of Dec. 2023)

View and export this data going back to 2002. Start your Free Trial

What is Marksans Pharma Accounts Payable & Accrued Expense?

Marksans Pharma's quarterly accounts payable & accrued expense increased from Jun. 2023 (₹0 Mil) to Sep. 2023 (₹2,418 Mil) but then declined from Sep. 2023 (₹2,418 Mil) to Dec. 2023 (₹0 Mil).

Marksans Pharma's annual accounts payable & accrued expense increased from Mar. 2021 (₹1,782 Mil) to Mar. 2022 (₹2,127 Mil) and increased from Mar. 2022 (₹2,127 Mil) to Mar. 2023 (₹2,516 Mil).

Marksans Pharma Accounts Payable & Accrued Expense Historical Data

The historical data trend for Marksans Pharma's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marksans Pharma Accounts Payable & Accrued Expense Chart

Marksans Pharma Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

1,134.04

1,177.26

1,782.45

2,126.86

2,516.31

Marksans Pharma Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															-	2,516.31	-	2,417.89	-

Marksans Pharma Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Marksans Pharma (NSE:MARKSANS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Marksans Pharma Ltd (NSE:MARKSANS) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

524404:India

Address

Veera Desai Extension Road, 11th Floor, Grandeur, Opposite Gundecha Symphony, Oshiwara, Andheri (West), Mumbai, MH, IND, 400053

Website

http://www.marksanspharma.com

Marksans Pharma Ltd is a pharmaceutical company. The company is engaged in the research, manufacturing, and marketing of pharmaceutical formulations. It manufactures analgesics, gastroenterology, anti-diabetic, cardiovascular, pain management, gynecology, gastrointestinal and oncologic drugs as well as antibiotics and antiallergic medications. It has a market presence with the majority of the revenue generated from the United States and North America, followed by Europe and the UK, Australia and New Zealand, India, and the Rest of the World.

Marksans Pharma (NSE:MARKSANS) Headlines

No Headlines